Phreesia Inc

Phreesia Inc

PHR

Get informed when a big investor buys or sells

+ Follow
Market Cap$773.27M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Phreesia IncPhreesia Inc82.2--3%1.60.4
$12.17

Target Price by Analysts

3.6% downsidePhreesia Target Price DetailsTarget Price
$29.73

Current Fair Value

135.6% upside

Undervalued by 135.6% based on the discounted cash flow analysis.

Share Statistics

Market cap$773.27 Million
Enterprise Value$830.68 Million
Dividend Yield$- (-)
Earnings per Share$0.04
Beta0.87
Outstanding Shares60,944,962

Return

Return on Equity-2.73%ROE
Return on Assets-1.47%
Return on Invested Capital-0.18%

Valuation & Multiples

P/E Ratio82.19P/E Ratio
PEG-30.94PEG
Price to Sales1.58Price to Sales
Price to Book Ratio2.52Price to Book Ratio
Enterprise Value to Revenue1.68
Enterprise Value to EBIT-915.85
Enterprise Value to Net Income-85
Total Debt to Enterprise0.16
Debt to Equity0.37Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 28, 2026
EPS Estimate
$0.02
Average shareholder expectation
Revenue Estimate
$130.09 M
Average shareholder expectation

Next Earnings Call

Expected Date
September 3, 2026
EPS Estimate
$0.11
Average shareholder expectation
Revenue Estimate
$129.06 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.3356 313.28%
Total Calls29,500 64.11%
Total Puts9,900 96.53%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %22.24% 76.02%
Total Invested$139.25M 71.89%
Investors Holding76 176.00%

ESG Score

No data

About Phreesia Inc

CEO: Chaim Indig

Phreesia gives healthcare organizations a suite of robust applications to manage the patient intake process. Our innovative SaaS platform engages patients and provides a modern, convenient experience, while enabling our clients to optimi...